Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data – TechCrunch
Another COVID-19 vaccine is about to go on sale – a single vaccine from Johnson & Johnson’s pharmaceutical subsidiary Janssen. The company just released an efficacy report based on data from its Phase 3 study that found the new vaccine to be 66% overall effective at preventing moderate to severe incarnations of COVID-19 in those … Read more